Brian Taylor Slingsby, Director, 10% Owner at Mineralys Therapeutics, Inc. (MLYS), bought 518,518 shares at $13.50 ($7.0M) on 2025-03-13, disclosed to the SEC on 2025-04-25.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $13.50 | 259,259 | $3.5M | 50.0% |
| 2 | $13.50 | 259,259 | $3.5M | 50.0% |
| Total | $13.50 avg | 518,518 | $7.0M | 100% |
| Filing → |
| MLYS | BUY | 2023-02-16 | $4.0M | — | Filing → |